Literature DB >> 23870639

The natural history of coronary calcification: a meta-analysis from St Francis and EBEAT trials.

Michael Y Henein1, George Koulaouzidis, Gabriel Granåsen, Urban Wiklund, Alan Guerci, Axel Schmermund.   

Abstract

BACKGROUND AND AIM: Coronary artery calcium score (CACs) is an established quantitative tool for assessing subclinical atherosclerosis. The aim of this study was to assess in a meta-analysis model the natural history and reproducibility of CACs measurements obtained from St Francis and EBEAT trials.
METHODS: We analysed data from 649 individuals: 443 on placebo with 2 year follow-up from St Francis trial (Study A) and 209 on 10 mg atorvastatin with 1 year follow-up of EBEAT trial (Study B). Total CACs and that in the left coronary artery (LCA) branches, left main stem (LMS), left anterior descending (LAD), left circumflex (Cx) and right coronary artery (RCA) were analysed. In view of the wide CACs spectrum, data were logarithmically transformed before the analyses and mixed model analysis was used to evaluate the change of CACs over time.
RESULTS: The overall agreement between the two measurements was fairly good, showing a small but significant increase in CAC: 68% of the group as a whole presented an increase in CACs, 23% of the cohort had negligible change in CACs of <10% irrespective of the baseline CACs; and the remaining 10% showed a fall in CACs. Both studies showed similar patterns. The analysis of individual coronary arteries showed significantly higher variability of measurements in the RCA than in the LCA. Males had higher baseline CACs than females, but the rate of progression was not different between genders, irrespectively of age and baseline score.
CONCLUSION: The natural history of CACs was overtime progression in the majority of subjects, irrespective of gender. The higher variability in RCA measurements could be related to the low baseline CACs or exaggerated movement of the right side atrioventricular ring, whereas those for LCA branches are influenced by the branch allocation of the CACs. Large changes to and from zero, might be related to technical limitations.
© 2013.

Entities:  

Keywords:  Coronary artery calcification; Coronary calcium score; Meta-analysis; Natural history; Progression

Mesh:

Year:  2013        PMID: 23870639     DOI: 10.1016/j.ijcard.2013.06.057

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Impact of menaquinone-4 supplementation on coronary artery calcification and arterial stiffness: an open label single arm study.

Authors:  Yuji Ikari; Sho Torii; Atsushi Shioi; Toshio Okano
Journal:  Nutr J       Date:  2016-05-12       Impact factor: 3.271

2.  Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial).

Authors:  Liv M Vossen; Leon J Schurgers; Bernard J van Varik; Bas L J H Kietselaer; Cees Vermeer; Johannes G Meeder; Braim M Rahel; Yvonne J M van Cauteren; Ge A Hoffland; Roger J M W Rennenberg; Koen D Reesink; Peter W de Leeuw; Abraham A Kroon
Journal:  Nutrients       Date:  2015-10-28       Impact factor: 5.717

3.  Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome.

Authors:  Jiayu Wang; Xianwei Huang; Caihua Fu; Qiping Sheng; Ping Liu
Journal:  Cardiovasc Diabetol       Date:  2022-09-16       Impact factor: 8.949

Review 4.  Pharmacological and Nutritional Modulation of Vascular Calcification.

Authors:  Liv M Vossen; Abraham A Kroon; Leon J Schurgers; Peter W de Leeuw
Journal:  Nutrients       Date:  2019-12-30       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.